Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
650.9 INR | -1.33% | +2.11% | -9.95% |
Kurzporträt
Mitarbeiterzahl: 1 193
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Manufacturing (CRAMS)
100,0
%
| 13 202 | 100,0 % | 13 403 | 100,0 % | +1.52% |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Europe
86,7
%
| 11 048 | 83,7 % | 11 618 | 86,7 % | +5.16% |
United States
6,2
%
| 585 | 4,4 % | 834 | 6,2 % | +42.47% |
Rest of the World
4,5
%
| 1 126 | 8,5 % | 600 | 4,5 % | -46.70% |
India
2,6
%
| 443 | 3,4 % | 352 | 2,6 % | -20.64% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 29.09.23 |
Himanshu Agarwal
DFI | Director of Finance/CFO | 30 | 01.01. |
Chief Tech/Sci/R&D Officer | - | - | |
Compliance Officer | - | - | |
Director/Board Member | - | 29.09.23 | |
Corporate Officer/Principal | - | 01.10.23 | |
Corporate Officer/Principal | - | 29.09.23 | |
Corporate Officer/Principal | - | - | |
Corporate Officer/Principal | - | - | |
C. Rajendiran
PRN | Corporate Officer/Principal | 63 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 67 | 29.09.23 | |
Shweta Jalan
BRD | Director/Board Member | 48 | 09.11. |
Director/Board Member | 62 | 09.11. | |
Vinod Rao
BRD | Director/Board Member | 61 | 29.09.23 |
Chairman | 64 | 29.09.23 | |
Director/Board Member | - | 29.09.23 | |
Director/Board Member | 66 | 29.09.23 | |
Pankaj Patwari
BRD | Director/Board Member | - | 29.09.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 254 564 956 | 95 412 871 ( 37,48 %) | 0 | 37,48 % |
Unternehmenskontakt
Suven Pharmaceuticals Ltd.
Door No. 8-2-334, 3rd Floor SDE Serene Chambers, Road No.5
500034, Hyderabad
+91 40 2354 9414
http://www.suvenpharm.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Casper Pharma Pvt Ltd.
Casper Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Suven Pharmaceuticals Ltd., Casper Pharma Pvt Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hyderabad, India. The company was founded in 2016. Casper Pharma was acquired by Suven Pharmaceuticals Ltd. on June 30, 2022 for $20.75 million. |
Pharmaceuticals: Major
|
Sektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-9.95% | 1.99 Mrd. | |
+35.01% | 664 Mrd. | |
+28.36% | 567 Mrd. | |
-6.72% | 354 Mrd. | |
+19.71% | 330 Mrd. | |
+3.96% | 286 Mrd. | |
+13.25% | 234 Mrd. | |
+4.80% | 199 Mrd. | |
-10.39% | 196 Mrd. | |
-4.81% | 148 Mrd. |
- Börse
- Aktien
- SUVENPHAR Aktie
- Unternehmen Suven Pharmaceuticals Limited